Search
education › ... › admissions
… Program at Baylor College of Medicine is dedicated to admitting a select cohort of exceptional students who … strong academic performance, clinical potential, and a commitment to advancing the cardiovascular perfusion profession. The program is committed to welcoming applicants from varied cultural, individual, and …
departments › ... › child-neurology-residency
… accredited program that provides exceptional opportunities to study neurological diseases of children from infancy … sleep medicine, stroke, autism, multiple sclerosis, and autoimmune & infectious encephalitides. Opened in 1954, Texas … hospital and a tertiary referral center. All medical, laboratory and nursing services are geared to the unique …
research › ... › symptoms
… of medical advisors and community advisors to determine the best way to measure pelvic floor dysfunction in women with … Check out our Facebook page! …
support › ... › webmail-faqs
… have been moved to your OneDrive for Business cloud storage account. Go to mail.bcm.edu, enter your BCM email address …
education › ... › master-clinician-award
… of patient identifiers. To view scoring information, visit Master Clinician Scoring Sheet . For further information visit Frequently Asked Questions . …
departments › ... › vaccine-trial-volunteer-interest-form
… If you are in good general health and able to complete visits to Baylor College of Medicine, we would like to hear …
education › ... › admissions
… Program. Student admission practices are non-discriminatory with respect to race, ethnicity, creed, gender, sexual preference, age, … Admissions Match through National Matching Services. Visit the NMS website to register for the match, review detailed information about …
news › biological-e-limited-to-begin-phase-iii-clinical-trials-with-baylor-and-texas-childrens-vaccine
… E. Limited (BE), an Indian vaccine and pharmaceutical company, announced that it has completed the Phase I/II … subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs … Biological E. Limited to begin Phase III clinical trials with Baylor and Texas …
healthcare › clinical-trials › h-48387
… study in Parkinson's disease patients with dyskinesia to assess the efficacy and safety/tolerability of fixed dose combinations of JM-010 and its individual components. … dyskinesia. An investigational drug is one that is not approved by the United Stated Food and Drug Administration …
healthcare › clinical-trials › h-41067
… antibodies are antibodies which have been engineered to recognize and bind to a specific type of protein. RO7046015 binds to a protein called alpha synuclein, which is found in the … PASADENA: A Study to Evaluate Intravenous RO7046015 (PRX002) in Participants …